Point72 Asset Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,616,244
| Closed | -$8.21M | – | 1217 |
|
|
2024
Q1 | $8.21M | Buy |
+1,616,244
| New | +$8.21M | 0.02% | 636 |
|
|
2023
Q4 | – | Sell |
-2,758,813
| Closed | -$19.5M | – | 1424 |
|
|
2023
Q3 | $19.5M | Sell |
2,758,813
-1,245,887
| -31% | -$8.82M | 0.06% | 376 |
|
|
2023
Q2 | $28.2M | Buy |
4,004,700
+3,951,200
| +7,385% | +$27.8M | 0.08% | 267 |
|
|
2023
Q1 | $446K | Sell |
53,500
-1,935,127
| -97% | -$16.1M | ﹤0.01% | 944 |
|
|
2022
Q4 | $22.8M | Buy |
+1,988,627
| New | +$22.8M | 0.08% | 296 |
|
|
2022
Q3 | – | Sell |
-644,100
| Closed | -$6.82M | – | 1037 |
|
|
2022
Q2 | $6.82M | Buy |
+644,100
| New | +$6.82M | 0.03% | 545 |
|
|
2022
Q1 | – | Sell |
-25,272
| Closed | -$350K | – | 1069 |
|
|
2021
Q4 | $350K | Sell |
25,272
-178,641
| -88% | -$2.47M | ﹤0.01% | 918 |
|
|
2021
Q3 | $2.93M | Buy |
+203,913
| New | +$2.93M | 0.01% | 693 |
|
|
2021
Q1 | – | Sell |
-3,230,800
| Closed | -$24.1M | – | 906 |
|
|
2020
Q4 | $24.1M | Buy |
3,230,800
+2,598,200
| +411% | +$19.4M | 0.12% | 231 |
|
|
2020
Q3 | $2.17M | Sell |
632,600
-254,970
| -29% | -$876K | 0.01% | 646 |
|
|
2020
Q2 | $4.23M | Sell |
887,570
-2,130,562
| -71% | -$10.2M | 0.03% | 475 |
|
|
2020
Q1 | $6.04M | Sell |
3,018,132
-5,364,768
| -64% | -$10.7M | 0.05% | 342 |
|
|
2019
Q4 | $28.9M | Buy |
8,382,900
+5,122,900
| +157% | +$17.7M | 0.15% | 182 |
|
|
2019
Q3 | $9.34M | Buy |
+3,260,000
| New | +$9.34M | 0.06% | 345 |
|
|
2019
Q2 | – | Sell |
-47,453
| Closed | -$386K | – | 1240 |
|
|
2019
Q1 | $386K | Sell |
47,453
-302,547
| -86% | -$2.46M | ﹤0.01% | 790 |
|
|
2018
Q4 | $2.83M | Buy |
+350,000
| New | +$2.83M | 0.01% | 579 |
|
|
2018
Q1 | – | Sell |
-933,766
| Closed | -$4.59M | – | 790 |
|
|
2017
Q4 | $4.59M | Buy |
+933,766
| New | +$4.59M | 0.02% | 499 |
|
|
2015
Q3 | – | Sell |
-2,000
| Closed | -$30K | – | 704 |
|
|
2015
Q2 | $30K | Buy |
+2,000
| New | +$30K | ﹤0.01% | 643 |
|